CASI Pharmaceuticals Appoints Daniel Lang as New CFO and SVP
CASI Pharmaceuticals, Inc. has appointed Daniel Lang, MD as Chief Financial Officer and Senior Vice President.
Athenex Cell Therapy | 09/07/2024 | By Aishwarya | 217
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy